Eltrombopag, low‐dose rituximab, and dexamethasone combination as frontline treatment of newly diagnosed immune thrombocytopaenia

Detalles Bibliográficos
Autores principales: Gómez Almaguer, David, Colunga Pedraza, Perla Rocío, Gómez de León, Andrés, Gutiérrez Aguirre, César Homero, Cantú Rodríguez, Olga Graciela, Jaime Pérez, José Carlos
Formato: Artículo
Lenguaje:inglés
Publicado: 2019
Acceso en línea:http://eprints.uanl.mx/15810/1/12.pdf
_version_ 1824414388477493248
author Gómez Almaguer, David
Colunga Pedraza, Perla Rocío
Gómez de León, Andrés
Gutiérrez Aguirre, César Homero
Cantú Rodríguez, Olga Graciela
Jaime Pérez, José Carlos
author_facet Gómez Almaguer, David
Colunga Pedraza, Perla Rocío
Gómez de León, Andrés
Gutiérrez Aguirre, César Homero
Cantú Rodríguez, Olga Graciela
Jaime Pérez, José Carlos
author_sort Gómez Almaguer, David
collection Repositorio Institucional
format Article
id eprints-15810
institution UANL
language English
publishDate 2019
record_format eprints
spelling eprints-158102022-04-08T23:28:45Z http://eprints.uanl.mx/15810/ Eltrombopag, low‐dose rituximab, and dexamethasone combination as frontline treatment of newly diagnosed immune thrombocytopaenia Gómez Almaguer, David Colunga Pedraza, Perla Rocío Gómez de León, Andrés Gutiérrez Aguirre, César Homero Cantú Rodríguez, Olga Graciela Jaime Pérez, José Carlos 2019-12-21 Article PeerReviewed text en cc_by_nc_nd http://eprints.uanl.mx/15810/1/12.pdf http://eprints.uanl.mx/15810/1.haspreviewThumbnailVersion/12.pdf Gómez Almaguer, David y Colunga Pedraza, Perla Rocío y Gómez de León, Andrés y Gutiérrez Aguirre, César Homero y Cantú Rodríguez, Olga Graciela y Jaime Pérez, José Carlos (2019) Eltrombopag, low‐dose rituximab, and dexamethasone combination as frontline treatment of newly diagnosed immune thrombocytopaenia. British journal of haematology, 184 (2). pp. 288-290. ISSN 0007-1048 http://doi.org/10.1111/bjh.15070 doi:10.1111/bjh.15070
spellingShingle Gómez Almaguer, David
Colunga Pedraza, Perla Rocío
Gómez de León, Andrés
Gutiérrez Aguirre, César Homero
Cantú Rodríguez, Olga Graciela
Jaime Pérez, José Carlos
Eltrombopag, low‐dose rituximab, and dexamethasone combination as frontline treatment of newly diagnosed immune thrombocytopaenia
thumbnail https://rediab.uanl.mx/themes/sandal5/images/online.png
title Eltrombopag, low‐dose rituximab, and dexamethasone combination as frontline treatment of newly diagnosed immune thrombocytopaenia
title_full Eltrombopag, low‐dose rituximab, and dexamethasone combination as frontline treatment of newly diagnosed immune thrombocytopaenia
title_fullStr Eltrombopag, low‐dose rituximab, and dexamethasone combination as frontline treatment of newly diagnosed immune thrombocytopaenia
title_full_unstemmed Eltrombopag, low‐dose rituximab, and dexamethasone combination as frontline treatment of newly diagnosed immune thrombocytopaenia
title_short Eltrombopag, low‐dose rituximab, and dexamethasone combination as frontline treatment of newly diagnosed immune thrombocytopaenia
title_sort eltrombopag low dose rituximab and dexamethasone combination as frontline treatment of newly diagnosed immune thrombocytopaenia
url http://eprints.uanl.mx/15810/1/12.pdf
work_keys_str_mv AT gomezalmaguerdavid eltrombopaglowdoserituximabanddexamethasonecombinationasfrontlinetreatmentofnewlydiagnosedimmunethrombocytopaenia
AT colungapedrazaperlarocio eltrombopaglowdoserituximabanddexamethasonecombinationasfrontlinetreatmentofnewlydiagnosedimmunethrombocytopaenia
AT gomezdeleonandres eltrombopaglowdoserituximabanddexamethasonecombinationasfrontlinetreatmentofnewlydiagnosedimmunethrombocytopaenia
AT gutierrezaguirrecesarhomero eltrombopaglowdoserituximabanddexamethasonecombinationasfrontlinetreatmentofnewlydiagnosedimmunethrombocytopaenia
AT canturodriguezolgagraciela eltrombopaglowdoserituximabanddexamethasonecombinationasfrontlinetreatmentofnewlydiagnosedimmunethrombocytopaenia
AT jaimeperezjosecarlos eltrombopaglowdoserituximabanddexamethasonecombinationasfrontlinetreatmentofnewlydiagnosedimmunethrombocytopaenia